To address our hypothesis that a tumor-mediated ET-1 effect is involved in the development of cardiac remodeling in breast cancer patients, we first set out to explore this in immunocompromised mice that had human breast cancer cells injected into their subcutaneous flank (Figure 1A, Supplemental Figure 1A) to establish tumors. The gene discussed is EDN1; the disease is breast cancer.